CRIS Current Research Information System

PICCINNI, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.725
AS - Asia 3.685
EU - Europa 3.655
AF - Africa 248
SA - Sud America 242
Continente sconosciuto - Info sul continente non disponibili 213
OC - Oceania 6
Totale 12.774
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.650
IT - Italia 1.112
VN - Vietnam 972
SG - Singapore 962
CN - Cina 834
GB - Regno Unito 811
DE - Germania 453
HK - Hong Kong 383
SE - Svezia 324
FR - Francia 218
IN - India 184
RU - Federazione Russa 182
BR - Brasile 178
UA - Ucraina 148
IE - Irlanda 112
JP - Giappone 91
ZA - Sudafrica 83
CI - Costa d'Avorio 78
NL - Olanda 68
EE - Estonia 56
FI - Finlandia 45
BD - Bangladesh 43
CA - Canada 43
TG - Togo 42
PH - Filippine 31
BE - Belgio 30
AR - Argentina 29
JO - Giordania 23
TW - Taiwan 22
TH - Thailandia 21
AT - Austria 18
ID - Indonesia 15
MX - Messico 15
KR - Corea 14
CH - Svizzera 13
NG - Nigeria 13
PK - Pakistan 13
SC - Seychelles 12
SA - Arabia Saudita 11
PL - Polonia 10
TR - Turchia 10
UZ - Uzbekistan 10
CO - Colombia 9
HR - Croazia 9
IQ - Iraq 9
EC - Ecuador 8
LB - Libano 8
GR - Grecia 7
LT - Lituania 7
AU - Australia 6
ES - Italia 6
CL - Cile 5
CR - Costa Rica 5
DK - Danimarca 5
IR - Iran 5
KE - Kenya 5
PY - Paraguay 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
JM - Giamaica 4
MA - Marocco 4
MY - Malesia 4
NP - Nepal 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
EG - Egitto 3
PE - Perù 3
RO - Romania 3
TN - Tunisia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
GT - Guatemala 2
LY - Libia 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
DZ - Algeria 1
EU - Europa 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LV - Lettonia 1
MQ - Martinica 1
MT - Malta 1
MV - Maldive 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SO - Somalia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 12.564
Salva come PNG Salva come JPEG
Città #
Southend 701
Singapore 605
Ashburn 401
Chandler 361
Hong Kong 351
Fairfield 338
Santa Clara 323
San Jose 281
Ho Chi Minh City 234
Dong Ket 199
Wilmington 197
Princeton 193
Hanoi 155
Ann Arbor 150
Houston 150
Woodbridge 148
Beijing 119
Seattle 117
Dublin 107
Boardman 106
Los Angeles 102
Cambridge 98
Council Bluffs 96
Bologna 94
Dallas 88
Jacksonville 86
Lauterbourg 85
Rome 80
Abidjan 78
Nanjing 78
Westminster 78
Padova 75
Tokyo 66
Milan 52
Medford 49
Buffalo 43
Shenyang 43
Helsinki 42
Lomé 42
Saint Petersburg 39
New York 36
Berlin 35
Bremen 34
Dearborn 34
Mülheim 33
Brussels 28
Changsha 27
Nanchang 27
Da Nang 26
Frankfurt am Main 26
Jinan 26
Redwood City 26
Amman 23
Olalla 23
San Diego 23
Redondo Beach 22
Guangzhou 21
Hebei 21
San Venanzo 21
The Dalles 21
Turin 21
Hefei 20
Palermo 20
Shanghai 20
Florence 19
São Paulo 19
Munich 17
Tianjin 17
Zhengzhou 17
Bari 16
Haiphong 16
Falls Church 15
Hangzhou 15
London 15
Phoenix 15
Haikou 14
Taipei 14
Abeokuta 13
Chicago 13
Bangkok 12
Kunming 12
Norwalk 12
Orem 12
Toronto 12
Biella 11
Biên Hòa 11
Jiaxing 11
Naples 11
Ningbo 11
Yubileyny 11
Lanzhou 10
Messina 10
Hải Dương 9
Montreal 9
Redmond 9
Torino 9
Trieste 9
Brooklyn 8
Bühl 8
Cagliari 8
Totale 7.714
Salva come PNG Salva come JPEG
Nome #
Leucoencefalopatia Multifocale Progressiva: complicanza dell'immunosoppressione o reazione avversa da farmaci? 624
Data Mining Techniques in Pharmacovigilance: Analysis of the Publicly Accessible FDA Adverse Event Reporting System (AERS) 310
Farmacoutilizzazione in ospedale: analisi delle variabilità in una realtà regionale 295
Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies 281
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy 263
Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy 247
Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones: A Disproportionality Analysis of the US FDA Adverse Event Reporting System Database. 230
Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs (ESPEA): a population-based study on prescription patterns, pregnancy outcomes and fetal health 229
Predictors of antipsychotic prescription in a Northern Italian District (Bologna) 220
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 209
Association between Paraesthesia and Local Anesthetics: Data Mining of the Public Version of the FDA Adverse Event Reporting System, 205
Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based survey 199
Social and clinical descriptors of antipsychotic prescription 197
A real-world study on unmet medical needs in triptan-treated migraine: Prevalence, preventive therapies and triptan use modification from a large Italian population along two years 195
Triptans and serious adverse vascular events: Data mining of the FDA Adverse Event Reporting System database 194
Prescription patterns of antiepileptic drugs in young women: development of a tool to distinguish between epilepsy and psychiatric disorders 192
Determinanti demografici, clinici ed organizzativi dell'aderenza alla poli-terapia dopo infarto miocardico acuto 191
Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents. 190
Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting 189
Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study 187
Clinically important drug-drug interactions in poly-treated elderly outpatients: A campaign to improve appropriateness in general practice 187
Disproportionality signal of progressive multifocal leukoencephalopathy: monoclonal antibodies versus other immunosuppressants 186
Paraesthesia after Local Anaesthetics: An Analysis of Reports to the FDA Adverse Event Reporting System 172
Organisational determinants of adherence to secondary prevention medications after acute myocardial infarction 172
Predictors of non-adherence with oral bisphosphonates: an Italian retrospective cohort study on administrative databases 164
La condivisione dei trattamenti farmacologici in psichiatria e la percezione degli effetti avversi ai farmaci antipisicotici da medico, paziente e familiare 164
Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective 163
Fattori determinanti nell'utilizzo dei farmaci antipsicotici 162
Use and Perception of Phytoestrogens in Postmenopausal Women: Result of a Questionnaire-Based Survey 159
Impact of notoriety bias on reporting of pancreatitis with antidiabetics: the case of exenatide 157
Profili di utilizzo dei farmaci antipsicotici nei centri salute mentale della AUSL di Bologna: determinanti clinici e sociali 157
Triptans and serious cardiovascular events: possible safety signals from the FDA Adverse Event Reporting System database 156
Determinanti demografici, clinici ed organizzativi dell’aderenza alla poli-terapia dopo infarto miocardico acuto 156
Aderenza al trattamento con Bifosfonati: studio di coorte retrospettivo su database amministrativi dell’Emilia Romagna 156
Infarto del miocardio, edema maculare e fratture associate ai glitazoni: analisi del database di segnalazione spontanea FDA_AERS 152
The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database. 151
Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study 149
Progressive Multifocal Leukoencephalopathy: an effect of immunodeficiency or an adverse drug reaction? 148
Prescription patterns of oral bisphosphonates in Italian patients with osteoporosis 148
Pioglitazone-associated bladder cancer: the contribution of spontaneous reporting analysis on the basis of FDA_AERS database 146
Cardiovascular events in statin recipients: a 3-year record-linkage study on prescription and hospital discharge databases 145
Safety profile of thiazolidinediones on the basis of the FDA-AERS database: cardiovascular and bone fracture risks for rosiglitazone and pioglitazone 145
La rimborsabilità di memantina - il trilemma di Münchausen 143
Risk-management of natalizumab: a drug utilization study on duration of therapy and cause of discontinuation in Emilia-Romagna region 142
Trends in antiarrhythmic drug use after marketing authorization of dronedarone: comparison between Emilia Romagna (Italy) and Sweden. 140
Analyses of natalizumab prescriptions and discontinuations in multiple sclerosis patients of an Italian region 140
Progetto europeo di confronto dell'uso dei farmaci 137
Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures 136
Aderenza alla terapia antidepressiva in Emilia-Romagna 133
Progressive Multifocal Leukoencephalopathy (PML): only immunosuppressive complication or also drug adverse reaction? 133
Trend in SSRI-SNRI antidepressants prescription over a 6-year period and predictors of poor adherence 133
Burden of community-acquired pneumonia in Italian general practice 132
Psychiatrists’ Use of Shared Decision Making in the Treatment of Psychosis: The “Farmaci and Famiglie” Project in Bologna 130
Healthcare of patients with immunoglobulin A nephropathy through a retrospective observational study of Italian administrative data 129
A project for monitoring disease modifying drug prescriptions for multiple sclerosis in Emilia Romagna 128
The key role of patient in the antipsychotic therapy: shared decision making, adherence and research 127
Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to Bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures, 125
The pharmacovigilance program on natalizumab in Italy: 2 years of experience 125
Natalizumab: a country-based surveillance program 124
Three years of experience: the Italian registry and safety data update 122
Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database. 121
Glucagon-like peptide 1-based drugs and pancreatic safety. 114
Progetto di monitoraggio della prescrizione di farmaci disease-modifying nella sclerosi multipla in Emilia-Romagna 114
I rapporti tra medici, pazienti e familiari nella scelta delle terapie farmacologiche dei disturbi psichici: un’indagine presso il dipartimento di salute mentale della AUSL di Bologna 113
Monitoring the use of disease-modifying drugs in multiple sclerosis 112
The Italian Surveillance Program on Natalizumab 108
VII Report Health Search Anno 2011/2012 105
Drug-related Progressive Multifocal Leukoencephalopathy (PML): datamining of FDA_AERS (Adverse Event Reporting System) 105
Factors Influencing the Disproportional Association Between Triptans and Cerebrovascular Events Within the FDA_AERS Database: Causal Association or Reporting Bias? 105
Lack of adherence to oral bisphosphonates in Italian patients: prevalence and predictors 104
Prescrizione di Entacapone nella Regione Emilia-Romagna 104
L’uso dei farmaci in Italia. Rapporto nazionale anno 2011 103
Drug-induced Progressive Multifocal Leukoencephalopathy: data mining of international spontaneous ADR report databases 102
Interrupted time series analysis on the impact of dronedarone authorisation on Italian and Swedish antiarrhythmic prescriptions 100
Insights into real-world treatment of cluster headache through a large Italian database: prevalence, prescription patterns, and costs 100
Monitoring disease-modifying drugs in multiple sclerosis in Emilia Romagna 99
The Italian Natalizumab Registry: a 1-year follow-up 97
Impact of dronedarone authorisation on antiarrhythmic utilisation: interrupted time series strategy on Italian and Swedish prescription databases 85
Use of disease-modifying drugs for multiple sclerosis in neurological centres of Emilia Romagna 84
Drug utilisation of antidepressants in Generai Practice: choice of drugs and adherence in an Italian region 78
Totale 12.774
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.222
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.222
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.313 0 66 69 105 127 93 28 87 45 98 356 239
2022/20231.598 195 199 116 212 88 116 40 108 261 64 142 57
2023/2024563 44 79 38 70 57 50 38 31 25 46 58 27
2024/20251.616 99 239 110 116 421 107 86 48 21 74 32 263
2025/20263.777 194 290 368 188 457 216 622 129 654 356 179 124
2026/2027258 73 185 0 0 0 0 0 0 0 0 0 0
Totale 12.774